Takeda presents orexin data from landmark oveporexton phase 3 programme in narcolepsy type 1 at World Sleep 2025: Singapore Tuesday, September 9, 2025, 13:00 Hrs [IST] Takeda will ...

Today's successful businesses operate with a lean, permanent core surrounded by a dynamic, on-demand layer of world-class ...

Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, a potential first-in-class investigational oral orexin ...

The poster presentation can be found on Alterity’s website here.

Below, we’ve compiled the 50 greatest rap songs about sex, spread across more than four decades. You might want to have your headphones on for this one; these tracks are definitely NSFW, unless you’ve ...

Elanco Animal Health Incorporated ( NYSE: ELAN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 8:30 AM EDT Hi. Good morning, everyone. I'm Erin Wright, Healthcare Services ...

Axsome Therapeutics, Inc. ( NASDAQ: AXSM) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Good afternoon, everyone, and welcome to Morgan Stanley Global ...

Impact on the 12 core human capacities will be more negatively than positively in the next 10 years, says more than half of ...

COPENHAGEN, Denmark, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR ...

The intersection of U.S. 17 and Wells Road is within the project limits of FDOT’s I-295 and U.S. 17 interchange improvements and resurfacing project. 22 minutes ago People in Orange Park are making ...

Saudi Arabia has introduced Tourism and Hospitality as a core subject for third-grade secondary students, alongside new electives like Artificial Intelligence, Cybersecurity, Fashion, and First Aid.

WILMETTE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. ("Monopar” or the "Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative ...